IFNAR1 and colitis: In the acute experimental colitis model induced by dextran sulfate sodium (DSS), the deletion of the Ifnar1 would exacerbate the disease progression, whereas administration of recombinant type I interferon exerts protective effects against colitis through acting on myeloid cells [123].